rs35222922

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_001199397.3(NEK1):​c.859C>G​(p.Pro287Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,529,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00016 ( 0 hom., cov: 30)
Exomes š‘“: 0.00011 ( 0 hom. )

Consequence

NEK1
NM_001199397.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 2.22
Variant links:
Genes affected
NEK1 (HGNC:7744): (NIMA related kinase 1) The protein encoded by this gene is a serine/threonine kinase involved in cell cycle regulation. The encoded protein is found in a centrosomal complex with FEZ1, a neuronal protein that plays a role in axonal development. Defects in this gene are a cause of polycystic kidney disease (PKD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005516529).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000158 (24/151844) while in subpopulation EAS AF = 0.00426 (22/5166). AF 95% confidence interval is 0.00288. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEK1NM_001199397.3 linkc.859C>G p.Pro287Ala missense_variant Exon 11 of 36 ENST00000507142.6 NP_001186326.1 Q96PY6-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEK1ENST00000507142.6 linkc.859C>G p.Pro287Ala missense_variant Exon 11 of 36 1 NM_001199397.3 ENSP00000424757.2 Q96PY6-3

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
151726
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00425
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000388
AC:
59
AN:
152054
AF XY:
0.000435
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00559
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000107
AC:
148
AN:
1377240
Hom.:
0
Cov.:
26
AF XY:
0.000100
AC XY:
68
AN XY:
680154
show subpopulations
Gnomad4 AFR exome
AF:
0.00
AC:
0
AN:
30930
Gnomad4 AMR exome
AF:
0.00
AC:
0
AN:
34752
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
24964
Gnomad4 EAS exome
AF:
0.00329
AC:
116
AN:
35216
Gnomad4 SAS exome
AF:
0.000181
AC:
14
AN:
77256
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
49214
Gnomad4 NFE exome
AF:
9.42e-7
AC:
1
AN:
1061954
Gnomad4 Remaining exome
AF:
0.000297
AC:
17
AN:
57296
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
151844
Hom.:
0
Cov.:
30
AF XY:
0.000121
AC XY:
9
AN XY:
74210
show subpopulations
Gnomad4 AFR
AF:
0.00
AC:
0
AN:
0
Gnomad4 AMR
AF:
0.00
AC:
0
AN:
0
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00426
AC:
0.00425861
AN:
0.00425861
Gnomad4 SAS
AF:
0.000208
AC:
0.0002079
AN:
0.0002079
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.00
AC:
0
AN:
0
Gnomad4 OTH
AF:
0.000475
AC:
0.000475285
AN:
0.000475285
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000238
ExAC
AF:
0.000101
AC:
9
Asia WGS
AF:
0.00173
AC:
6
AN:
3474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Mar 01, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The NEK1 c.859C>G; p.Pro287Ala variant (rs35222922) is reported in the literature in individuals affected with amyotrophic lateral sclerosis (Pang 2017), but has not been reported in association with skeletal dysplasia. This variant is reported in ClinVar (Variation ID: 598999), and is found in the East Asian population with an allele frequency of 0.59% (72/12112 alleles) in the Genome Aggregation Database. The proline at codon 287 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Due to limited information, the clinical significance of the p.Pro287Ala variant is uncertain at this time. References: Pang et al. Burden of rare variants in ALS genes influences survival in familial and sporadic ALS. Neurobiol Aging. 2017 Oct;58:238.e9-238.e15. -

Nov 19, 2018
Center for Personalized Medicine, Children's Hospital Los Angeles
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Connective tissue disorder Uncertain:1
May 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NEK1-related disorder Benign:1
May 28, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Short-rib thoracic dysplasia 6 with or without polydactyly Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
13
DANN
Benign
0.18
DEOGEN2
Benign
0.062
T;.;.;.;.
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.84
T;T;T;T;T
M_CAP
Benign
0.0095
T
MetaRNN
Benign
0.0055
T;T;T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
1.5
L;L;L;L;L
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.2
N;N;N;N;N
REVEL
Benign
0.064
Sift
Benign
0.42
T;T;T;T;T
Sift4G
Benign
0.43
T;T;T;T;T
Polyphen
0.0020
B;.;B;B;B
Vest4
0.11
MVP
0.70
MPC
0.053
ClinPred
0.026
T
GERP RS
4.8
Varity_R
0.083
gMVP
0.27
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35222922; hg19: chr4-170502002; API